Navigation Links
Dr. Adam Locketz of Minneapolis-St. Paul Joins The Coleman Institute Network
Date:9/25/2017

The Coleman Institute, a leader in opioid addiction treatment specializing in detoxification, announced today the addition of an affiliate in Minneapolis-St. Paul, MN, Dr. Adam Locketz. Dr. Locketz will be offering a full range of treatment services including accelerated detox, Naltrexone therapy and aftercare planning through his Timewise Medical practice in the twin cities.

Dr. Locketz graduated from the University of Minnesota School of Medicine in 2001, and was awarded an Internal and Physical Medicine residency at the Mayo Clinic College of Medicine in 2005, followed by a 2006 Fellowship in Anesthesia Pain Medicine. With specialties in Anesthesia Pain Medicine, Physical Medicine and Rehabilitation, Dr. Locketz takes an active interest in providing comprehensive pain management alongside of addiction recovery. A large part of his patient base are Veterans for whom Dr. Locketz has a special interest, seeking the best ways to manage chronic musculoskeletal, spine, and other painful problems.

With the needs and best interests of the patients in mind, conservative therapies are used to eliminate pain with the use of medical marijuana as supported by the State of Minnesota also employed to provide comprehensive, modern pain management. The Timewise Medical practice also offers outpatient treatment for the addiction of opioids, benzodiazepines and alcohol.

Dr. Locketz stated, “When I can help someone to recover from substance use disorder, it gives me great satisfaction as a health care provider. My experience with addiction has shown me there are many different paths for healing, and Dr. Coleman’s approach to recovery from Opioid Use Disorder provides yet another way I can be of services to my patients. I am grateful to be able to offer a variety of services help my patients in the way that works best for them.”

The Coleman Institute has developed a unique and customizable approach to assisting patients in overcoming their physical dependency on opiates and then accessing the long-term support resources needed to maintain their sobriety. Dr. Peter Coleman, through his own experiences, recognized that detoxification was a critical piece of this process. If not addressed with a medically competent methodology, the physical symptoms of withdrawal make successful completion challenging, if not impossible, for those struggling with addiction. The combination of detoxification and after-care support, including Naltrexone therapy, provides patients with a comprehensive, individualized treatment plan offering the real possibility of experiencing long-term sobriety.

Dr. Peter Coleman, founder and National Medical Director for The Coleman Institute added, “I am happy to have Dr. Locketz, with his passion for providing evidence-based treatment for his patients, join our Coleman team. We share a focus and passion for providing our patients the opportunity to lead happy, healthy and productive lives.”

For more information on The Coleman Institute, or to find a location near you, visit: http://www.TheColemanInstitute.com

About The Coleman Institute:

Since 1998, The Coleman Institute has helped thousands of patients detoxify and recover from the effects of heroin use and other opioids such as OxyContin, Percocet and Vicodin. The Coleman Institute’s unique Accelerated Opiate Detoxification treatment enables over 98% of its patients to successfully complete their detox and begin Naltrexone therapy.

The Coleman Institute has eight offices nationwide (Richmond, Seattle, Metro Chicago, Phoenix Southern California, Northern California, Central Texas and Tampa Bay).

Read the full story at http://www.prweb.com/releases/2017/09/prweb14731761.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Chad Gorman, M.D. joins Physician Partners of America Pain Relief Group - New Port Richey
2. Top Lyme Disease Researcher Joins Global Lyme Alliance as New Chief Scientific Officer
3. Strategic Marketing Leader Joins DeSola Group
4. Canyon Ranch Joins ACLM’s Lifestyle Medicine Corporate Roundtable as Industry Leader in Integrative Wellness Lifestyle-Enhancement Properties
5. Dr. Deborah Ohlhausen Joins Shoal Creek Office of Dermatology & Skin Cancer Centers, Now Part of U.S. Dermatology Partners, on September 18
6. Dr. Matthew Hoffmann, Joins U.S. Dermatology Partners Longview Office September 18th
7. Roswell Park Cancer Institute Joins ORIEN Personalized Medicine Consortium
8. Altec Joins e2b Teknologies at Their Innovate 2017 Conference as Exhibitor Sponsor
9. Dr. Lee Witt Joins Gilreath Dental Associates in Marietta
10. Essential Dental Systems Joins In the Hurricane Harvey Relief Efforts
11. Christopher Creighton, M.D., Joins Richardson, Texas, Pain Relief Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
Breaking Medicine Technology: